Marker Therapeutics Other Income and Expenses (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.39 -0.05 (-3.47%) USD | NASDAQ | Mar 05, 16:00

1.40 +0.01 (+0.72%) Pre-Market: 20:00

View Other Income and Expenses (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Income and Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Income and Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Income and Expenses (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	Upgrade
Viridian Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	Upgrade
Kiniksa Pharmaceuticals International Plc	Upgrade
Neurocrine Biosciences, Inc.	Upgrade